查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1614210

肠道疾病检测市场：按产品、疾病类型、诊断技术、检测地点 - 全球预测 2025-2030

Enteric Disease Testing Market by Product (Consumables, Kits, Reagents), Disease Type (Bacterial, Parasitic, Viral), Diagnostic Techniques, Testing Site - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年肠道疾病检测市场价值为43.1亿美元，预计到2024年将达到45.4亿美元，复合年增长率为5.47%，到2030年预计将达到62.6亿美元。

肠道疾病检测的范围包括识别由病毒、细菌和寄生虫引起的胃肠道感染疾病的诊断方法。这种检测对于公共卫生监测和临床管理都至关重要，可以及时介入以控制疫情并确保适当的治疗。应用范围广泛，包括诊断实验室、医院、诊所、公共卫生组织等。最终用途领域包括从专注于患者护理的医疗设施到开发先进诊断工具的研究机构。

主要市场统计
基准年[2023] 43.1亿美元
预计年份 [2024] 45.4亿美元
预测年份 [2030] 62.6亿美元
复合年增长率（%） 5.47%

市场成长受到全球旅行者数量增加和气候变迁导致肠道疾病发病率增加等因素的显着影响，气候变迁影响病原体的分布。分子诊断技术的进步以及人们对感染疾病早期检测和管理重要性的认识不断提高，增加了对快速、准确诊断方法的需求。机会比比皆是，包括非侵入性检测的创新和就地检验套件的开发，以到达缺乏传统检测基础设施的偏远和资源匮乏的环境。

然而，市场面临局限性，特别是在新兴市场，包括与先进诊断技术相关的高成本以及缺乏操作先进设备的熟练人员。监管障碍也减缓了新测试解决方案的采用。诸如需要对新测试进行广泛验证和病原体的可变代表性等挑战使标准化工作变得更加复杂。

创新应着重于提高测试灵敏度和特异性，同时降低成本并提高可近性。可以在一次测试中检测多种病原体的多重检测的研究特别有前景。此外，开发便携式且易于使用的设备用于疫情爆发情况下的现场测试可以扩大市场开拓。

这是一个竞争激烈但充满活力的市场，由持续的研究和技术进步所定义，这些研究和技术进步有望推动进一步成长，同时解决当前的挑战。策略伙伴关係、併购以及专注于开发具有成本效益的解决方案，对于在不断变化的环境中实现业务扩张至关重要。

市场动态：揭示快速发展的肠道疾病检测市场的关键市场洞察

肠道疾病检测市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 由于卫生条件差和供水受污染，肠道疾病盛行率不断上升
    • 诊断测试的创新描述了更高的灵敏度、特异性和更快的结果
    • 政府和非政府组织为对抗感染疾病所做的努力
  • 市场限制因素
    • 新兴国家先进测试成本上升且基础设施缺乏
  • 市场机会
    • 加大医疗基础建设投资，注重预防诊断
    • 研发活动和市场拓展的策略联盟和合作关係
  • 市场问题
    • 产品核准和商业化规定

波特五力：开拓肠道疾病检测市场的策略工具

波特五力：框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解肠道疾病检测市场的外部影响

外部宏观环境因素对肠道疾病检测市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解肠道疾病检测市场的竞争格局

对肠道疾病检测市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：肠道疾病检测市场供应商绩效评估

FPNV定位矩阵是评估肠道疾病检测市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製肠道疾病检测市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对肠道疾病检测市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 由于卫生条件不佳和水污染导致肠道疾病传播
      • 诊断测试的技术创新提高了灵敏度、特异性，并更快地得出结果。
      • 政府和非政府组织为对抗感染疾病所做的努力
    • 抑制因素
      • 新兴国家先进测试高成本且基础设施缺乏
    • 机会
      • 增加对卫生基础设施的投资并专注于预防性诊断
      • 研发活动和市场拓展的策略伙伴关係和合作
    • 任务
      • 产品核准和商业化规定
  • 市场区隔分析
    • 疾病类型：在细菌检测中更多地采用多重和分子诊断方法
    • 检测地点：快速诊断对于医院即时患者照护至关重要
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章肠道疾病检测市场：副产品

  • 介绍
  • 消耗品
  • 套件
  • 试剂

第七章肠道疾病检测市场：依疾病类型

  • 介绍
  • 细菌
    • 霍乱
    • 大肠桿菌
    • 沙门氏菌病
  • 寄生虫
  • 病毒

第八章肠道疾病检测市场：透过诊断技术

  • 介绍
  • 免疫检测
  • 分子诊断
    • PCR
    • 即时PCR
  • 快速诊断
    • 量油尺
    • 横向流动化验

第九章肠道疾病检测市场：依检测地点

  • 介绍
  • 医院内部
  • 照护现场
  • 独立实验室

第十章美洲肠道疾病检验市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太肠道疾病检验市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东、非洲肠道疾病检测市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • FDA核准MeMed BV Direct 从全血中提取
    • Avacta 收购欧洲诊断测试製造商
    • 默克透过收购 Prometheus Biosciences, Inc. 加强了免疫学产品线。
  • 战略分析和建议

公司名单

  • 3M Company
  • Abbott Laboratories
  • Als Limited
  • Asure Quality
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomerica Inc.
  • bioMerieux SA
  • Bureau Veritas Group
  • Cepheid Inc.
  • Coris BioConcept SPRL
  • DiaSorin
  • Eurofins Scientific SE
  • Hardy Diagnostics
  • Intertek Group PLC
  • Merck & Co., Inc.
  • Merck KGAA
  • Meridian Bioscience Inc.
  • Merieux NutriSciences Corporation
  • Neogen Corporation
  • Nova Biologicals
  • Perkinelmer, Inc.
  • Qiagen NV
  • Quest Diagnostics
  • Romer Labs Division Holding GmbH
  • SGS SA
  • Symbio Laboratories
  • Thermo Fisher Scientific Inc.
  • Trinity BIoTech PLC
  • TUV SUD AG
Product Code: MRR-732E7CFCB4A5

The Enteric Disease Testing Market was valued at USD 4.31 billion in 2023, expected to reach USD 4.54 billion in 2024, and is projected to grow at a CAGR of 5.47%, to USD 6.26 billion by 2030.

The scope of enteric disease testing encompasses diagnostic methods used to identify infections within the gastrointestinal tract caused by viruses, bacteria, and parasites. This testing is crucial for both public health surveillance and clinical management, enabling timely interventions to control outbreaks and ensure appropriate medical treatment. Applications are widespread and include diagnostic labs, hospitals, clinics, and public health organizations. End-use sectors range from healthcare facilities focusing on patient care to research institutions developing advanced diagnostic tools.

KEY MARKET STATISTICS
Base Year [2023] USD 4.31 billion
Estimated Year [2024] USD 4.54 billion
Forecast Year [2030] USD 6.26 billion
CAGR (%) 5.47%

Market growth is significantly influenced by factors such as rising incidence of enteric diseases due to more global travel and changes in climate, which affect pathogen distribution. The demand for rapid, accurate diagnostic methods is increasing, driven by technological advancements in molecular diagnostics and the rising awareness about the importance of early detection and management of infections. Opportunities abound in the innovation of non-invasive testing methods and the development of point-of-care testing kits, which cater to remote or resource-poor settings where traditional lab infrastructure may be lacking.

However, the market faces limitations, including high costs associated with advanced diagnostic technologies and a lack of skilled personnel to operate sophisticated equipment, particularly in developing regions. Regulatory hurdles can also slow the introduction of new testing solutions. Challenges such as the need for extensive validation of novel tests and the variability in pathogen presentation complicate standardization efforts.

Innovation should focus on enhancing the sensitivity and specificity of tests while reducing costs and improving accessibility. Research into multiplex assays capable of detecting multiple pathogens in a single test is particularly promising. Additionally, developing portable, easy-to-use devices for field testing in outbreak scenarios can broaden market reach.

The market is competitive but dynamic, defined by ongoing research and technological progress that promises to address current challenges while driving further growth. Strategic partnerships, mergers, and acquisitions, along with a focus on developing cost-efficient solutions, will be crucial for business expansion in this evolving landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Enteric Disease Testing Market

The Enteric Disease Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of enteric diseases due to poor sanitation and contaminated water supplies
    • Technological innovations in diagnostic tests offer greater sensitivity, specificity, and faster results
    • Governmental and non-governmental organizations' initiatives to control infectious diseases
  • Market Restraints
    • High cost of advanced tests and the lack of infrastructure in emerging countries
  • Market Opportunities
    • Increasing investment in healthcare infrastructure and the focus on preventive diagnostics
    • Strategic partnerships and collaborations for R&D activities and market expansion
  • Market Challenges
    • Regulations concerning the approval and commercialization of product

Porter's Five Forces: A Strategic Tool for Navigating the Enteric Disease Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Enteric Disease Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Enteric Disease Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Enteric Disease Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Enteric Disease Testing Market

A detailed market share analysis in the Enteric Disease Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Enteric Disease Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Enteric Disease Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Enteric Disease Testing Market

A strategic analysis of the Enteric Disease Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Enteric Disease Testing Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Als Limited, Asure Quality, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomerica Inc., bioMerieux SA, Bureau Veritas Group, Cepheid Inc., Coris BioConcept SPRL, DiaSorin, Eurofins Scientific SE, Hardy Diagnostics, Intertek Group PLC, Merck & Co., Inc., Merck KGAA, Meridian Bioscience Inc., Merieux NutriSciences Corporation, Neogen Corporation, Nova Biologicals, Perkinelmer, Inc., Qiagen N.V., Quest Diagnostics, Romer Labs Division Holding GmbH, SGS SA, Symbio Laboratories, Thermo Fisher Scientific Inc., Trinity Biotech PLC, and TUV SUD AG.

Market Segmentation & Coverage

This research report categorizes the Enteric Disease Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables, Kits, and Reagents.
  • Based on Disease Type, market is studied across Bacterial, Parasitic, and Viral. The Bacterial is further studied across Cholera, Escherichia coli, and Salmonellosis.
  • Based on Diagnostic Techniques, market is studied across Immunoassays, Molecular Diagnostics, and Rapid Diagnostics. The Molecular Diagnostics is further studied across PCR and Real-time PCR. The Rapid Diagnostics is further studied across Dipsticks and Lateral Flow Assays.
  • Based on Testing Site, market is studied across In-Hospital, Point-of-Care, and Standalone Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of enteric diseases due to poor sanitation and contaminated water supplies
      • 5.1.1.2. Technological innovations in diagnostic tests offer greater sensitivity, specificity, and faster results
      • 5.1.1.3. Governmental and non-governmental organizations' initiatives to control infectious diseases
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of advanced tests and the lack of infrastructure in emerging countries
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investment in healthcare infrastructure and the focus on preventive diagnostics
      • 5.1.3.2. Strategic partnerships and collaborations for R&D activities and market expansion
    • 5.1.4. Challenges
      • 5.1.4.1. Regulations concerning the approval and commercialization of product
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Disease Type: Increasing preference for multiplex and molecular diagnostic methods for bacterial testing
    • 5.2.2. Testing Site: Need for rapid diagnostics crucial for immediate patient care in hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Enteric Disease Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Kits
  • 6.4. Reagents

7. Enteric Disease Testing Market, by Disease Type

  • 7.1. Introduction
  • 7.2. Bacterial
    • 7.2.1. Cholera
    • 7.2.2. Escherichia coli
    • 7.2.3. Salmonellosis
  • 7.3. Parasitic
  • 7.4. Viral

8. Enteric Disease Testing Market, by Diagnostic Techniques

  • 8.1. Introduction
  • 8.2. Immunoassays
  • 8.3. Molecular Diagnostics
    • 8.3.1. PCR
    • 8.3.2. Real-time PCR
  • 8.4. Rapid Diagnostics
    • 8.4.1. Dipsticks
    • 8.4.2. Lateral Flow Assays

9. Enteric Disease Testing Market, by Testing Site

  • 9.1. Introduction
  • 9.2. In-Hospital
  • 9.3. Point-of-Care
  • 9.4. Standalone Laboratories

10. Americas Enteric Disease Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Enteric Disease Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Enteric Disease Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. FDA Clears MeMed BV Direct from Whole Blood
    • 13.3.2. Avacta Acquires European Diagnostic Test Maker
    • 13.3.3. Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Abbott Laboratories
  • 3. Als Limited
  • 4. Asure Quality
  • 5. Becton, Dickinson and Company
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Biomerica Inc.
  • 8. bioMerieux SA
  • 9. Bureau Veritas Group
  • 10. Cepheid Inc.
  • 11. Coris BioConcept SPRL
  • 12. DiaSorin
  • 13. Eurofins Scientific SE
  • 14. Hardy Diagnostics
  • 15. Intertek Group PLC
  • 16. Merck & Co., Inc.
  • 17. Merck KGAA
  • 18. Meridian Bioscience Inc.
  • 19. Merieux NutriSciences Corporation
  • 20. Neogen Corporation
  • 21. Nova Biologicals
  • 22. Perkinelmer, Inc.
  • 23. Qiagen N.V.
  • 24. Quest Diagnostics
  • 25. Romer Labs Division Holding GmbH
  • 26. SGS SA
  • 27. Symbio Laboratories
  • 28. Thermo Fisher Scientific Inc.
  • 29. Trinity Biotech PLC
  • 30. TUV SUD AG

LIST OF FIGURES

  • FIGURE 1. ENTERIC DISEASE TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. ENTERIC DISEASE TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ENTERIC DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ENTERIC DISEASE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ENTERIC DISEASE TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ENTERIC DISEASE TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CHOLERA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY ESCHERICHIA COLI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SALMONELLOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PARASITIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY VIRAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIPSTICKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IN-HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY STANDALONE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 155. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 162. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 177. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 184. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 191. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 198. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 205. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 212. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 219. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 226. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 233. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 240. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 247. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 254. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 261. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 268. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 282. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 289. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 296. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 303. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 310. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 311. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 324. ENTERIC DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 325. ENTERIC DISEASE TESTING MARKET, FPNV POSITIONING MATRIX, 2023